Definitive Contract HHSD200201795780C
Award Date
9/29/17
Potential Completion Date
9/28/22
Potential Value
$7.5M
Federal Agency
CDC Pittsburgh
Awardee
Vysnova Partners, LLC
Ultimate Awardee
Not listed
NAICS Category
541618 - Other Management Consulting Services
PSC Category
B537 - Special Studies/Analysis- Medical/Health
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Bethesda, MD 20814, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
4
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $10,047,532.00 definitive, cost-plus-fixed-fee contract awarded by the Centers for Disease Control and Prevention (CDC) to Vysnova Partners, LLC, a for-profit limited liability company, to conduct the Colombia Cohort Zika Study. The contract is not set aside. Vysnova Partners is a professional services firm that specializes in providing support for medical research, clinical trials, disease surveillance, and global health initiatives. The company holds several significant federal...
This is a $2,999,342 cost-plus-fixed-fee definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Vysnova Partners, LLC, a for-profit limited liability company. The contract is for enhancing surveillance and cohort studies, and it runs through September 30, 2018. Vysnova Partners has expertise in areas such as clinical trials, data analysis, vector surveillance, and administrative program management. This award is not a set-aside contract. Vysnova Partners holds...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price contract to Georgia State University Research Foundation Inc., a non-profit organization and foundation, for $1,530,000.00 to conduct Zika diagnostic and vector research. The contract has an April 16, 2022 completion date and was awarded on April 17, 2017. This contract is not designated as a set-aside. The Georgia State University Research Foundation Inc. has previously received...
The Centers for Disease Control and Prevention (CDC) awarded a $500,000 firm fixed price contract to The Johns Hopkins University to support Zika diagnostic and vector research efforts. Under the terms of the two-year agreement, set to run from July 2017 through June 2019, the prime contractor will deliver products and services to assist the CDC in addressing the Zika virus. No major subcontractors or set aside designations were indicated. This award advances the CDC's mission to monitor and...
This is a $3,279,000.00 firm-fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC), an agency within the U.S. Department of Health and Human Services (HHS), to the University of North Carolina at Chapel Hill (UNC) to conduct research related to the Zika virus and its vector. The contract, which does not have a set-aside designation, was awarded on April 17, 2017, with a completion date of April 16, 2022. UNC, through its Office of Sponsored Research,...
This federal contract award is for clinical sample testing services in support of Zika virus vaccine evaluation and research. The Department of Health and Human Services' National Institute of Allergy and Infectious Diseases awarded a $3,315,351.08 delivery order contract to Battelle Memorial Institute, a large nonprofit R&D organization, to provide these services. The contract does not have a set-aside designation. As the prime contractor, Battelle has subcontracted with several vendors...
This is a $335,333,551.74 definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Takeda Vaccines Inc. for the development of a Zika virus vaccine. The contract has a period of performance through September 30, 2024. It is a cost-plus-fixed-fee contract with no set-aside designation. The contract supports ASPR's Zika virus research and vaccine development initiatives. As the prime contractor, Takeda Vaccines Inc. is leading the effort and...
This is a $14,640,019.00 cost-plus-fixed-fee delivery order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Leidos Biomedical Research Inc. to manufacture and test Zika virus or Zika-related virus vaccine products. The contract is not set aside. Leidos Biomedical Research, a subsidiary of Leidos Holdings Inc., has a history of supporting federal biomedical research programs at...
This is a Cost Plus Fixed Fee contract awarded by the Centers for Disease Control and Prevention (CDC) to Vysnova Partners, LLC, a for-profit limited liability company, for a prospective, natural history study of SARS-CoV-2 infection in Wake Forest healthcare workers. The $54,179,237.36 contract was awarded on July 1, 2020 with a period of performance through February 28, 2023. The original solicitation was Broad Agency Announcement number 75D301-20-R-67897, which sought white papers from...
This $395,529.61 federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services, to Battelle Memorial Institute, a nonprofit research and development organization, for clinical sample testing services related to Zika virus vaccines. The contract is a delivery order under the Evaluation and Testing Services (ETS) for Vaccines and Other Biologics for Infectious Diseases major program. It does...